These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 97720)

  • 61. Chronic administration of desipramine and imipramine but not zimelidine attenuates clonidine-induced depression of avoidance behavior in rats.
    Kostowski W; Obersztyn M
    Pol J Pharmacol Pharm; 1988; 40(4):341-9. PubMed ID: 2851779
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test.
    Kitada Y; Miyauchi T; Kanazawa Y; Nakamichi H; Satoh S
    Neuropharmacology; 1983 Sep; 22(9):1055-60. PubMed ID: 6314168
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acceleration of beta-receptor desensitization in combined administration of antidepressants and phenoxybenzamine.
    Crews FT; Paul SM; Goodwin FK
    Nature; 1981 Apr; 290(5809):787-9. PubMed ID: 6261156
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of amphetamine on locomotion in mice pretreated with desmethylimipramine, tetrabenazine or both.
    Weissman A
    Psychopharmacologia; 1972; 23(2):152-9. PubMed ID: 5022607
    [No Abstract]   [Full Text] [Related]  

  • 65. Effects of mianserin, desipramine and maprotiline on blood pressure responses evoked by acetylcholine, histamine and 5-hydroxytryptamine in rats.
    Cavero I; Lefèvre-Borg F; Roach AG
    Br J Pharmacol; 1981 Sep; 74(1):143-8. PubMed ID: 6115693
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antidepressant properties of 2-(4-ethyl-1-piperazinyl)-4-phenylquinoline hydrochloride (AD-1308) and its mechanism of action as compared with tricyclic antidepressants.
    Karasawa T; Furukawa K; Ochi Y; Ito T; Yoshida K; Shimizu M
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):283-302. PubMed ID: 6773486
    [No Abstract]   [Full Text] [Related]  

  • 67. Monoaminergic mechanisms of stimulation-produced analgesia.
    Akil H; Liebeskind JC
    Brain Res; 1975 Aug; 94(2):279-96. PubMed ID: 125141
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alteration in L-DOPA evoked dopamine and DOPAC output under conditions of impaired vesicular dopamine storage.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1998; 105(10-12):1091-101. PubMed ID: 9928880
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine.
    Bagchi SP
    Biochem Pharmacol; 1983 Oct; 32(19):2851-6. PubMed ID: 6626259
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tricyclic antidepressants vary in decreasing alpha 2-adrenoceptor sensitivity with chronic treatment: assessment with clonidine inhibition of acoustic startle.
    Davis M; Menkes DB
    Br J Pharmacol; 1982 Oct; 77(2):217-22. PubMed ID: 6291684
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A panic experimental model: validation of a complex operant behavioral method in undernourished rats, with desipramine to provide a template effect profile.
    Vigliecca NS; Molina SC; Peñalva MC
    J Pharmacol Toxicol Methods; 2007; 55(1):49-57. PubMed ID: 16581271
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Possible role of norepinephrine in cocaine-induced conditioned taste aversions.
    Serafine KM; Riley AL
    Pharmacol Biochem Behav; 2009 Mar; 92(1):111-6. PubMed ID: 19027784
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The effect of pimozide and phenoxybenzamine on the motor hyperactivity of rats treated with nialamide and dopamine (author's transl)].
    Malec D; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1975; 30():109-12. PubMed ID: 1230064
    [No Abstract]   [Full Text] [Related]  

  • 74. Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward.
    Yokel RA; Wise RA
    Science; 1975 Feb; 187(4176):547-9. PubMed ID: 1114313
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Desipramine administration in the olfactory bulbectomized rat: changes in brain beta-adrenoceptor and 5-HT2A binding sites and their relationship to behaviour.
    Mudunkotuwa NT; Horton RW
    Br J Pharmacol; 1996 Apr; 117(7):1481-6. PubMed ID: 8730743
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Some further observations of the effect of beta-phenethylamine on locomotor activity in mice.
    Jackson DM
    J Pharm Pharmacol; 1975 Apr; 27(4):278-80. PubMed ID: 239123
    [No Abstract]   [Full Text] [Related]  

  • 77. Reversal of reserpine-induced hypothermia by pharmacological agents other than antidepressants.
    Whittle BA
    Nature; 1967 Nov; 216(5115):579-80. PubMed ID: 5583498
    [No Abstract]   [Full Text] [Related]  

  • 78. Behavioural changes during withdrawal from desmethylimipramine (DMI). II. Increased resistance to extinction.
    Willner P; Montgomery T; Bird D
    Psychopharmacology (Berl); 1981; 75(1):60-4. PubMed ID: 6795662
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changes in amphetamine-induced anorexia and stereotypy during chronic treatment with antidepressant drugs.
    Willner P; Towell A; Montgomery T
    Eur J Pharmacol; 1984 Mar; 98(3-4):397-406. PubMed ID: 6586424
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Studies on interactions involving antidepressive and other drugs with tetrabenazine and noradnamine on locomotor activity in mice, including details of the experimental design and statistical analysis.
    Jones BJ; Tolman BD; Roberts DJ
    Psychopharmacologia; 1970; 18(3):288-99. PubMed ID: 5487291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.